Published in AIDS Weekly, September 15th, 2003
HAART became widespread in more-developed countries from 1996 onward, and has improved the prognosis of HIV-1 infection. However, not enough is known about how to predict the prognosis of people with HIV-1 infection starting HAART.
The initial measurement of specific immune response cells (CD4 cells) and viral load at the time patients start HAART is related to HIV/AIDS progression; in general, the lower the CD4 cell count and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.